Relapsed actinic keratosis evaluation: An observational Italian multicenter prospective study. Does gender have a role?

Giornale Italiano di Dermatologia e Venereologia

Volumn 149, Issue 2, 2014, Pages 199-204

  Javor, S ^a   Chimenti, S ^b   Patrizi, A ^c   Stingeni, L ^d   Pellacani, G ^e   Cavicchini, S ^f   Sala, R ^g   Rongioletti, F ^a   Parodi, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Actinic; Gender; Keratosis; Recurrence

Indexed keywords

ACTINIC KERATOSIS; AGED; ARTICLE; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NEOPLASM; RELAPSE; REMISSION; SEX DIFFERENCE;

ADULT; AGED; AMINOQUINOLINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; COHORT STUDIES; CRYOTHERAPY; CURETTAGE; DICLOFENAC; FEMALE; HUMANS; HYALURONIC ACID; ITALY; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; PROTECTIVE CLOTHING; RECURRENCE; REMISSION INDUCTION; SEX FACTORS; SUNSCREENING AGENTS;

EID: 84903181965     PISSN: 03920488     EISSN: 18271820     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marks R, Foley P, Goodman G, Hage BH, Selwood TS et al. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 1986;115:649-55. (Pubitemid 17181888)
2. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994;131:455-64. (Pubitemid 24315411)
3. Actinic Keratosis Treatments. Cigna Healthcare Coverage Position 2006. Available from: https://my.cigna.com/teamsite/health/provider/medical/ procedural/coverage-positions/medical/mm-0235-coveragepositioncriteria-actinic- keratosis-treatments.pdf
4. Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg 2007;33:1099-101. (Pubitemid 47339694)
5. Naldi L, Chatenoud L, Piccitto R, Colombo P, Placchesi EB, La Vecchia C, Prevalence of Actinic Keratoses Italian Study (PraKtis) Group et al. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population. Results from the prevalence of actinic keratoses Italian study, 2003-2004. Arch Dermatol 2006;142:722-6.
6. Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 1995;131:176-81.
7. Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg 2000;26:728-32. (Pubitemid 30620516)
8. Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002;138:1498-502. (Pubitemid 35315741)
9. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratosis. J Am Acad Dermatol 1982;7:631-2. (Pubitemid 12000529)
10. Piacquadio DJ, Chen DM, Farber HF, Fowler JF Jr, Glazer SD, Goodman JJ et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 2004;140:41-6. (Pubitemid 38090269)
11. M. Mastrolonardo. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses. Clin Exp Dermatol 2009;34:33-5.
12. Martin GM, Stockfleth E. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. J Drugs Dermatol 2012;11:600-8.
13. Ulrich C, Hackethal M, Ulrich M, Howorka A, Forschner T, Sterry W et al. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. Br J Dermatol 2007;156:40-2. (Pubitemid 46632515)
14. Fitzpatrick TB. The Validity and Practicality of Sun-Reactive Skin Types I Through VI. Arch Dermatol 1988;124:869-71.
15. Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006;16:599-606.
16. Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Austr J Dermatol 2003;44:40-5.
17. Wolf JE Jr, Taylor JR, Tschen E, Kang S et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001;40:709-13. (Pubitemid 34023642)